In the first half of the year, the retail sales of "LILANZ" products of CHINA LILANG (01234) achieved a low double-digit growth compared to the same period last year.
China Lirong (01234) announced that the retail amount (calculated at retail value) of "LILANZ" products in the second quarter of 2026 achieved a low double-digit growth compared to the same period in 2025.
CHINA LILANG (01234) announced that the retail sales amount of "LILANZ" products in the second quarter of 2026 (calculated at retail price) has achieved a low double-digit growth compared to the same period in 2025.
The retail sales amount of "LILANZ" products in the first half of 2026 (calculated at retail price) has achieved a low double-digit growth compared to the same period in 2025.
Related Articles
DMALL (02586) spent 3.0854 million Hong Kong dollars on buying back 506,700 shares on July 9th.
MICOT PHARMA-B(02335): The Phase II clinical trial of MT1002 for anticoagulation in hemodialysis patients has completed the enrollment of the first patient.
SCHOLAR EDU(01769): The trustee purchased a total of 1 million shares under the stock incentive plan.
DMALL (02586) spent 3.0854 million Hong Kong dollars on buying back 506,700 shares on July 9th.
MICOT PHARMA-B(02335): The Phase II clinical trial of MT1002 for anticoagulation in hemodialysis patients has completed the enrollment of the first patient.
SCHOLAR EDU(01769): The trustee purchased a total of 1 million shares under the stock incentive plan.
RECOMMEND
